Clinical Trials on Metabolic X Syndrome Dyslipidemia in United Kingdom
Total 3480 results
-
GlaxoSmithKlineCompletedHealthy Subjects | Dyslipidaemia | DyslipidaemiasUnited Kingdom
-
Xention LtdCompleted
-
Xention LtdCompleted
-
University of PennsylvaniaAbbottCompletedMetabolic Syndrome xUnited States
-
Novartis PharmaceuticalsCompletedDyslipidaemiaJordan, United States, Taiwan
-
Foundation Research, FloridaGlaxoSmithKline; Abbott; Kos PharmaceuticalsCompletedInsulin Resistance | Metabolic Syndrome XUnited States
-
GlaxoSmithKlineCompleted
-
University of WashingtonNational Heart, Lung, and Blood Institute (NHLBI)CompletedDyslipidemias | Metabolic Syndrome XUnited States
-
AstraZenecaCompleted
-
GlaxoSmithKlineCompleted
-
Novo Nordisk A/SRecruitingHealthy Volunteers | DyslipidaemiaUnited States
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedHealthy Subjects | DyslipidaemiasUnited States
-
GlaxoSmithKlineCompletedDyslipidemias | DyslipidaemiasUnited States
-
GlaxoSmithKlineCompletedHealthy Subjects | DyslipidaemiasUnited States
-
NorthSea Therapeutics B.V.CompletedDyslipidemiasUnited Kingdom
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
GlaxoSmithKlineCompletedDyslipidaemiasUnited States, Canada
-
Vital Signs Solutions LtdRecruiting
-
AstraZenecaParexelActive, not recruitingDyslipidemiaUnited States, United Kingdom
-
NeuroBo Pharmaceuticals Inc.CompletedSevere Hypertriglyceridemia | Mixed DyslipidaemiaUnited States, Canada
-
University of UlsterThe Regional Centre for Studies in Food and Health (CREAS), Valparaíso, ChileCompletedCardiovascular Diseases | Dyslipidemias | Lipid ProfileUnited Kingdom
-
University College DublinChelsea and Westminster NHS Foundation TrustUnknown
-
Rush University Medical CenterCompletedHyperglycemia | Hypertension | Obesity | Overweight | Dyslipidemias | Depressive Symptoms | Metabolic Syndrome XUnited States
-
Gary Van GuilderWestern Colorado University; Auckland University of TechnologyCompletedMetabolic Syndrome | Insulin Resistance | Endothelial Dysfunction | Atherogenic DyslipidemiaUnited States
-
GlaxoSmithKlineCompletedHealthy Subjects | DyslipidaemiasUnited States
-
Washington University School of MedicineNational Heart, Lung, and Blood Institute (NHLBI)CompletedHypertension | Overweight | Dyslipidemias | Prediabetic State | Metabolic Syndrome XUnited States
-
Washington University School of MedicineNational Heart, Lung, and Blood Institute (NHLBI); SingulexCompletedHypertension | Overweight | Dyslipidemias | Prediabetic State | Metabolic Syndrome XUnited States
-
University of NottinghamFlorida Department of CitrusCompletedObesity | Insulin Resistance | DyslipidemiaUnited Kingdom
-
GlaxoSmithKlineTerminatedHeart Failure | DyslipidaemiasUnited States
-
GlaxoSmithKlineCompletedAn Exploratory Study To Look At The Effect Of Two Investigational Drugs On Body Fat And InflammationObesity | Hypercholesterolemia | DyslipidaemiasUnited States
-
Oklahoma State UniversityCompletedMetabolic Syndrome | DyslipidemiasUnited States
-
University of California, DavisNational Heart, Lung, and Blood Institute (NHLBI)CompletedMetabolic Syndrome | Insulin Resistance | DyslipidemiaUnited States
-
Esperion Therapeutics, Inc.CompletedMild DyslipidemiaUnited States
-
AbbottCompletedMixed DyslipidemiaUnited States
-
Queen Margaret UniversityUnknownCardiovascular Diseases | Metabolic Syndrome XUnited Kingdom
-
University of California, DavisUniversity of California, San Francisco; USDA, Western Human Nutrition Research...Completed
-
University of California, DavisNational Heart, Lung, and Blood Institute (NHLBI)CompletedMetabolic Syndrome | Insulin Resistance | DyslipidemiaUnited States
-
University of Alabama at BirminghamNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedObesity | Metabolic Syndrome | DyslipidemiasUnited States
-
Novartis PharmaceuticalsRecruitingMixed Dyslipidemia | Primary HypercholesterolemiaSwitzerland, Saudi Arabia, United Arab Emirates, United Kingdom, Austria, Israel, China, Malaysia
-
Kowa Research EuropeCompletedDyslipidemia | HypercholesterolemiaFinland, Italy, Norway, Russian Federation, United Kingdom
-
Arrowhead PharmaceuticalsActive, not recruitingMixed DyslipidemiaUnited States, Australia, Canada, New Zealand
-
Silence Therapeutics plcMedpace, Inc.CompletedDyslipidemias | Hyperlipidemias | Elevated Lp(a)United States, Australia, United Kingdom, Netherlands
-
Arrowhead PharmaceuticalsCompletedMixed DyslipidemiaUnited States, Australia, Poland, New Zealand, Canada, Hungary
-
Pusan National UniversityUniversity of Nebraska; Dong-Eui UniversityCompletedHypertension | Metabolic Syndrome | Insulin Resistance | DyslipidemiasUnited States
-
University of Kansas Medical CenterUS Department of Veterans AffairsWithdrawnHypertension | Obesity | Insulin Resistance | Hypercholesterolemia | Metabolic Syndrome XUnited States
-
Tufts UniversityCompletedCardiovascular Diseases | Hyperlipidemias | Metabolic Syndrome XUnited States
-
Kowa Research EuropeCompletedHypercholesterolemia or Combined DyslipidemiaDenmark, Israel, Netherlands, Germany, United Kingdom
-
University of PennsylvaniaNational Heart, Lung, and Blood Institute (NHLBI); Arizona Pharmaceuticals...Completed